195 related articles for article (PubMed ID: 38285299)
1. Mid-term Effects of Bariatric Surgery on Metabolic Dysfunction-Associated Fatty Liver Disease Remission and Predictive Factors: A Prospective Study with a Focus on Non-invasive Diagnosis.
Navarro-Masip È; Mestres N; Zorzano-Martínez M; Salinas-Roca B; Sánchez E; López-Cano C; Herrerías F; de la Fuente MC; Santamaría M; León-Mengíbar J; Soler AG; Bueno M; Lecube A
Obes Surg; 2024 Mar; 34(3):841-849. PubMed ID: 38285299
[TBL] [Abstract][Full Text] [Related]
2. The HAALT Non-invasive Scoring System for NAFLD in Obesity.
Sheth H; Bagasrawala S; Shah M; Ansari R; Olithselvan A; Lakdawala M
Obes Surg; 2019 Aug; 29(8):2562-2570. PubMed ID: 31016455
[TBL] [Abstract][Full Text] [Related]
3. Metabolic Dysfunction-Associated Steatotic Liver Disease in Severe Obesity and Concordance Between Invasive (Biopsy) and Non-Invasive (OWLiver®) Diagnoses.
Navarro-Masip È; Mestres Petit N; Salinas-Roca B; Herrerías F; Vilardell F; de la Fuente MC; Pallares J; Santamaría M; Zorzano-Martínez M; Sánchez E; Matías-Guiu X; López-Cano C; Soler AG; León-Mengíbar J; Bueno M; Lecube A
Obes Facts; 2024 Jun; ():. PubMed ID: 38934179
[TBL] [Abstract][Full Text] [Related]
4. Bariatric surgery for non-alcoholic fatty liver disease in individuals with obesity (Base-NAFLD): protocol of a prospective multicenter observational follow-up study.
Wei L; Li M; Zeng N; Liu Y; Bai R; Zhang N; Song J; Zhang P; Yao Q; Yang Z; Zhao X; Zhang Y; Zhang P; Zhang Z
BMC Surg; 2021 Jun; 21(1):298. PubMed ID: 34167531
[TBL] [Abstract][Full Text] [Related]
5. A Pilot Study of Serum Sphingomyelin Dynamics in Subjects with Severe Obesity and Non-alcoholic Steatohepatitis after Sleeve Gastrectomy.
Ramos-Molina B; Castellano-Castillo D; Pastor O; Ocaña-Wilhelmi L; Fernández-García D; Romero-Gómez M; Cardona F; Tinahones FJ
Obes Surg; 2019 Mar; 29(3):983-989. PubMed ID: 30488259
[TBL] [Abstract][Full Text] [Related]
6. Bariatric Surgery and Metabolic Dysfunction-Associated Fatty Liver Disease: a 2022 Update.
Lazaridis II; Delko T
Praxis (Bern 1994); 2023 Feb; 112(2):97-102. PubMed ID: 36722105
[No Abstract] [Full Text] [Related]
7. Long-term Results of Bariatric Surgery for Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis Treatment in Morbidly Obese Japanese Patients.
Uehara D; Seki Y; Kakizaki S; Horiguchi N; Tojima H; Yamazaki Y; Sato K; Yamada M; Uraoka T; Kasama K
Obes Surg; 2019 Apr; 29(4):1195-1201. PubMed ID: 30542827
[TBL] [Abstract][Full Text] [Related]
8. The impact of bariatric surgery on nonalcoholic fatty liver disease as measured using non-invasive tests.
Netanel C; Goitein D; Rubin M; Kleinbaum Y; Katsherginsky S; Hermon H; Tsaraf K; Tachlytski I; Herman A; Safran M; Ben-Ari Z
Am J Surg; 2021 Jul; 222(1):214-219. PubMed ID: 33309037
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery.
Praveenraj P; Gomes RM; Kumar S; Karthikeyan P; Shankar A; Parthasarathi R; Senthilnathan P; Rajapandian S; Palanivelu C
Obes Surg; 2015 Nov; 25(11):2078-87. PubMed ID: 25835982
[TBL] [Abstract][Full Text] [Related]
10. HSCRP as surrogate marker in predicting long term effect of bariatric surgery on resolution of non-alcoholic steatohepatitis.
Tan CH; Al-Kalifah N; Lee WJ; Ser KH; Lee YC; Chen JC
Asian J Surg; 2019 Jan; 42(1):203-208. PubMed ID: 29804707
[TBL] [Abstract][Full Text] [Related]
11. The Effect of Non-Alcoholic Fatty Liver Disease on Weight Loss and Resolution of Obesity-Related Disorders After Bariatric Surgery.
Abdalla TSA; Giannou AD; Abdalla ASA; Izbicki JR; Dupreé A; Mann O; Wolter S
World J Surg; 2023 Dec; 47(12):3281-3288. PubMed ID: 37747548
[TBL] [Abstract][Full Text] [Related]
12. The Benefit of Bariatric Surgery on Histological Features of Metabolic Associated Fatty Liver Disease Assessed Through Noninvasive Methods.
Meneses D; Olveira A; Corripio R; Méndez MD; Romero M; Calvo-Viñuelas I; González-Pérez-de-Villar N; de-Cos-Blanco AI
Obes Surg; 2022 Aug; 32(8):2682-2695. PubMed ID: 35697996
[TBL] [Abstract][Full Text] [Related]
13. Non-invasive screening, staging and management of metabolic dysfunction-associated fatty liver disease (MAFLD) in type 2 diabetes mellitus patients: what do we know so far ?
Binet Q; Loumaye A; Preumont V; Thissen JP; Hermans MP; Lanthier N
Acta Gastroenterol Belg; 2022; 85(2):346-357. PubMed ID: 35709779
[TBL] [Abstract][Full Text] [Related]
14. Low-Grade Hepatic Steatosis Is Associated with Long-term Remission of Type 2 Diabetes Independent of Type of Bariatric-Metabolic Surgery.
Lautenbach A; Wernecke M; Mann O; Wagner J; Wolter S; Stoll F; Aberle J
Obes Surg; 2023 Feb; 33(2):530-538. PubMed ID: 36508157
[TBL] [Abstract][Full Text] [Related]
15. SCCA-IgM as a Potential Biomarker of Non-Alcoholic Fatty Liver Disease in Patients with Obesity, Prediabetes and Diabetes Undergoing Sleeve Gastrectomy.
Bettini S; Bordigato E; Milan G; Dal Pra' C; Favaretto F; Belligoli A; Sanna M; Serra R; Foletto M; Prevedello L; Busetto L; Fassina G; Vettor R; Fabris R
Obes Facts; 2019; 12(3):291-306. PubMed ID: 31104052
[TBL] [Abstract][Full Text] [Related]
16. Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery.
Tavaglione F; De Vincentis A; Bruni V; Gallo IF; Carotti S; Tuccinardi D; Spagnolo G; Ciociola E; Mancina RM; Jamialahmadi O; D'Alessio R; Bottazzi B; Manfrini S; Picardi A; Perrone G; Pozzilli P; Caricato M; Vespasiani-Gentilucci U; Romeo S
Liver Int; 2022 Feb; 42(2):374-383. PubMed ID: 34890093
[TBL] [Abstract][Full Text] [Related]
17. Bariatric Surgery as an Efficient Treatment for Non-Alcoholic Fatty Liver Disease in a Prospective Study with 1-Year Follow-up : BariScan Study.
Nickel F; Tapking C; Benner L; Sollors J; Billeter AT; Kenngott HG; Bokhary L; Schmid M; von Frankenberg M; Fischer L; Mueller S; Müller-Stich BP
Obes Surg; 2018 May; 28(5):1342-1350. PubMed ID: 29119336
[TBL] [Abstract][Full Text] [Related]
18. Long-term effect of bariatric surgery on resolution of nonalcoholic steatohepatitis (NASH): An external validation and application of a clinical NASH score.
Tan CH; Al-Kalifah N; Ser KH; Lee YC; Chen JC; Lee WJ
Surg Obes Relat Dis; 2018 Oct; 14(10):1600-1606. PubMed ID: 30077664
[TBL] [Abstract][Full Text] [Related]
19. Effect of bariatric surgery on NAFLD/NASH: a single-centre observational prospective cohort study.
Theel WB; Boxma-de Klerk BM; Dirksmeier-Harinck F; van Rossum EF; Kanhai DA; Apers JA; van Dalen BM; De Knegt RJ; Neecke B; van der Zwan EM; Grobbee DE; Hankemeier T; Wiebolt J; Castro Cabezas M
BMJ Open; 2023 Jul; 13(7):e070431. PubMed ID: 37400234
[TBL] [Abstract][Full Text] [Related]
20. Evolution of Non-alcoholic Fatty Liver Disease (NAFLD) Biomarkers in Response to Weight Loss 1 Year After Bariatric Surgery-a Post Hoc Analysis of the FibroTest Prospective Study.
Codjia T; Rebibo L; François A; Lagnel C; Huet E; Bekri S; Pattou F; Régimbeau JM; Schwarz L
Obes Surg; 2021 Aug; 31(8):3548-3556. PubMed ID: 33844174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]